Managed Healthcare Executive17h
WHO to Develop Lenacapavir and HIV Testing Guidelines
A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...
Hosted on MSN1d
Researchers expect FDA to approve a twice-yearly shot that reduces risk of HIV infection by 96%
Roughly 61,000 Georgians live with HIV, the sexually transmitted virus (STI) that can lead to AIDS, and Atlanta ranks in the ...
Glassman: How Trump can meet his goal of ending AIDS
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States ...
HIV drug lenacapavir is a breakthrough in treating AIDS
The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...
HIV in 2025: 'There Is Hope for the Future,' Say Disease Experts
Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
This HIV drug is hailed as 2024's Discovery of the Year
A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...